Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 50

1.

DisProt 7.0: a major update of the database of disordered proteins.

Piovesan D, Tabaro F, Mičetić I, Necci M, Quaglia F, Oldfield CJ, Aspromonte MC, Davey NE, Davidović R, Dosztányi Z, Elofsson A, Gasparini A, Hatos A, Kajava AV, Kalmar L, Leonardi E, Lazar T, Macedo-Ribeiro S, Macossay-Castillo M, Meszaros A, Minervini G, Murvai N, Pujols J, Roche DB, Salladini E, Schad E, Schramm A, Szabo B, Tantos A, Tonello F, Tsirigos KD, Veljković N, Ventura S, Vranken W, Warholm P, Uversky VN, Dunker AK, Longhi S, Tompa P, Tosatto SC.

Nucleic Acids Res. 2017 Jan 4;45(D1):D1123-D1124. doi: 10.1093/nar/gkw1279. Epub 2016 Dec 13. No abstract available.

2.

DisProt 7.0: a major update of the database of disordered proteins.

Piovesan D, Tabaro F, Mičetić I, Necci M, Quaglia F, Oldfield CJ, Aspromonte MC, Davey NE, Davidović R, Dosztányi Z, Elofsson A, Gasparini A, Hatos A, Kajava AV, Kalmar L, Leonardi E, Lazar T, Macedo-Ribeiro S, Macossay-Castillo M, Meszaros A, Minervini G, Murvai N, Pujols J, Roche DB, Salladini E, Schad E, Schramm A, Szabo B, Tantos A, Tonello F, Tsirigos KD, Veljković N, Ventura S, Vranken W, Warholm P, Uversky VN, Dunker AK, Longhi S, Tompa P, Tosatto SC.

Nucleic Acids Res. 2017 Jan 4;45(D1):D219-D227. doi: 10.1093/nar/gkw1056. Epub 2016 Nov 28. Erratum in: Nucleic Acids Res. 2017 Jan 4;45(D1):D1123-D1124.

3.

Predicted Enhanced Human Propensity of Current Avian-Like H1N1 Swine Influenza Virus from China.

Veljkovic V, Veljkovic N, Paessler S, Goeijenbier M, Perovic V, Glisic S, Muller CP.

PLoS One. 2016 Nov 9;11(11):e0165451. doi: 10.1371/journal.pone.0165451. eCollection 2016 Nov 9.

4.

TRI_tool: a web-tool for prediction of protein-protein interactions in human transcriptional regulation.

Perovic V, Sumonja N, Gemovic B, Toska E, Roberts SG, Veljkovic N.

Bioinformatics. 2017 Jan 15;33(2):289-291. doi: 10.1093/bioinformatics/btw590. Epub 2016 Sep 7.

PMID:
27605104
5.

An expanded evaluation of protein function prediction methods shows an improvement in accuracy.

Jiang Y, Oron TR, Clark WT, Bankapur AR, D'Andrea D, Lepore R, Funk CS, Kahanda I, Verspoor KM, Ben-Hur A, Koo da CE, Penfold-Brown D, Shasha D, Youngs N, Bonneau R, Lin A, Sahraeian SM, Martelli PL, Profiti G, Casadio R, Cao R, Zhong Z, Cheng J, Altenhoff A, Skunca N, Dessimoz C, Dogan T, Hakala K, Kaewphan S, Mehryary F, Salakoski T, Ginter F, Fang H, Smithers B, Oates M, Gough J, Törönen P, Koskinen P, Holm L, Chen CT, Hsu WL, Bryson K, Cozzetto D, Minneci F, Jones DT, Chapman S, Bkc D, Khan IK, Kihara D, Ofer D, Rappoport N, Stern A, Cibrian-Uhalte E, Denny P, Foulger RE, Hieta R, Legge D, Lovering RC, Magrane M, Melidoni AN, Mutowo-Meullenet P, Pichler K, Shypitsyna A, Li B, Zakeri P, ElShal S, Tranchevent LC, Das S, Dawson NL, Lee D, Lees JG, Sillitoe I, Bhat P, Nepusz T, Romero AE, Sasidharan R, Yang H, Paccanaro A, Gillis J, Sedeño-Cortés AE, Pavlidis P, Feng S, Cejuela JM, Goldberg T, Hamp T, Richter L, Salamov A, Gabaldon T, Marcet-Houben M, Supek F, Gong Q, Ning W, Zhou Y, Tian W, Falda M, Fontana P, Lavezzo E, Toppo S, Ferrari C, Giollo M, Piovesan D, Tosatto SC, Del Pozo A, Fernández JM, Maietta P, Valencia A, Tress ML, Benso A, Di Carlo S, Politano G, Savino A, Rehman HU, Re M, Mesiti M, Valentini G, Bargsten JW, van Dijk AD, Gemovic B, Glisic S, Perovic V, Veljkovic V, Veljkovic N, Almeida-E-Silva DC, Vencio RZ, Sharan M, Vogel J, Kansakar L, Zhang S, Vucetic S, Wang Z, Sternberg MJ, Wass MN, Huntley RP, Martin MJ, O'Donovan C, Robinson PN, Moreau Y, Tramontano A, Babbitt PC, Brenner SE, Linial M, Orengo CA, Rost B, Greene CS, Mooney SD, Friedberg I, Radivojac P.

Genome Biol. 2016 Sep 7;17(1):184. doi: 10.1186/s13059-016-1037-6.

6.

A combined ligand- and structure-based approach for the identification of rilmenidine-derived compounds which synergize the antitumor effects of doxorubicin.

Vucicevic J, Srdic-Rajic T, Pieroni M, Laurila JM, Perovic V, Tassini S, Azzali E, Costantino G, Glisic S, Agbaba D, Scheinin M, Nikolic K, Radi M, Veljkovic N.

Bioorg Med Chem. 2016 Jul 15;24(14):3174-83. doi: 10.1016/j.bmc.2016.05.043. Epub 2016 May 24.

PMID:
27265687
7.

Evolution of 2014/15 H3N2 Influenza Viruses Circulating in US: Consequences for Vaccine Effectiveness and Possible New Pandemic.

Veljkovic V, Paessler S, Glisic S, Prljic J, Perovic VR, Veljkovic N, Scotch M.

Front Microbiol. 2015 Dec 22;6:1456. doi: 10.3389/fmicb.2015.01456. eCollection 2015 Dec 22.

8.

Rilmenidine suppresses proliferation and promotes apoptosis via the mitochondrial pathway in human leukemic K562 cells.

Srdic-Rajic T, Nikolic K, Cavic M, Djokic I, Gemovic B, Perovic V, Veljkovic N.

Eur J Pharm Sci. 2016 Jan 1;81:172-80. doi: 10.1016/j.ejps.2015.10.017. Epub 2015 Oct 24.

PMID:
26598394
9.

Natural Products as Promising Therapeutics for Treatment of Influenza Disease.

Sencanski M, Radosevic D, Perovic V, Gemovic B, Stanojevic M, Veljkovic N, Glisic S.

Curr Pharm Des. 2015;21(38):5573-88. Review.

PMID:
26429712
10.

In silico analysis suggests repurposing of ibuprofen for prevention and treatment of EBOLA virus disease.

Veljkovic V, Goeijenbier M, Glisic S, Veljkovic N, Perovic VR, Sencanski M, Branch DR, Paessler S.

F1000Res. 2015 May 1;4:104. doi: 10.12688/f1000research.6436.1. eCollection 2015 May 1.

11.

Improving attrition rates in Ebola virus drug discovery.

Glisic S, Paessler S, Veljkovic N, Perovic VR, Prljic J, Veljkovic V.

Expert Opin Drug Discov. 2015;10(9):1025-32. doi: 10.1517/17460441.2015.1062872. Epub 2015 Jun 30. Review.

PMID:
26125997
12.

Preclinical discovery and development of maraviroc for the treatment of HIV.

Veljkovic N, Vucicevic J, Tassini S, Glisic S, Veljkovic V, Radi M.

Expert Opin Drug Discov. 2015 Jun;10(6):671-84. doi: 10.1517/17460441.2015.1041497. Epub 2015 Apr 30.

PMID:
25927601
13.

In silico analysis suggests interaction between Ebola virus and the extracellular matrix.

Veljkovic V, Glisic S, Muller CP, Scotch M, Branch DR, Perovic VR, Sencanski M, Veljkovic N, Colombatti A.

Front Microbiol. 2015 Feb 19;6:135. doi: 10.3389/fmicb.2015.00135. eCollection 2015 Feb 19.

14.

Virtual screen for repurposing approved and experimental drugs for candidate inhibitors of EBOLA virus infection.

Veljkovic V, Loiseau PM, Figadere B, Glisic S, Veljkovic N, Perovic VR, Cavanaugh DP, Branch DR.

F1000Res. 2015 Feb 2;4:34. doi: 10.12688/f1000research.6110.1. eCollection 2015 Feb 2.

15.

Demonstration of a direct interaction between β2-adrenergic receptor and insulin receptor by BRET and bioinformatics.

Mandić M, Drinovec L, Glisic S, Veljkovic N, Nøhr J, Vrecl M.

PLoS One. 2014 Nov 17;9(11):e112664. doi: 10.1371/journal.pone.0112664. eCollection 2014 Nov 17.

16.

CXCL16 haplotypes in patients with human carotid atherosclerosis: preliminary results.

Zivković M, Djurić T, Stojković L, Jovanović I, Končar I, Davidović L, Veljković N, Alavantić D, Stanković A.

J Atheroscler Thromb. 2015;22(1):10-20. doi: 10.5551/jat.24299. Epub 2014 Aug 19.

17.

Influenza vaccine as prevention for cardiovascular diseases: possible molecular mechanism.

Veljkovic V, Glisic S, Veljkovic N, Bojic T, Dietrich U, Perovic VR, Colombatti A.

Vaccine. 2014 Nov 12;32(48):6569-75. doi: 10.1016/j.vaccine.2014.07.007. Epub 2014 Jul 19.

PMID:
25045818
18.

Natural autoantibodies in healthy neonatals recognizing a peptide derived from the second conserved region of HIV-1 gp120.

Vujicić AD, Gemović B, Veljković V, Glisić S, Veljković N.

Vojnosanit Pregl. 2014 Apr;71(4):352-61.

PMID:
24783415
19.

Feature-based classification of amino acid substitutions outside conserved functional protein domains.

Gemovic B, Perovic V, Glisic S, Veljkovic N.

ScientificWorldJournal. 2013 Nov 17;2013:948617. doi: 10.1155/2013/948617. eCollection 2013 Nov 17.

20.

Novel phylogenetic algorithm to monitor human tropism in Egyptian H5N1-HPAIV reveals evolution toward efficient human-to-human transmission.

Perovic VR, Muller CP, Niman HL, Veljkovic N, Dietrich U, Tosic DD, Glisic S, Veljkovic V.

PLoS One. 2013 Apr 26;8(4):e61572. doi: 10.1371/journal.pone.0061572. Print 2013.

Supplemental Content

Loading ...
Support Center